Central Venous Catheters - Global Pipeline Analysis, Competitive Landscape

Jan. 20, 2012 - PRLog -- The global central venous catheters market was valued at $582.2m in 2010, having grown at a Compound Annual Growth Rate (CAGR) of 5.1% from $411.7m in 2003. The central venous catheters market is expected to grow at a CAGR of 3.2% to $727.4m in 2017. The antimicrobial central venous catheters market segment is expected to show the highest growth at a CAGR of 4.5% from 2010 to 2017.

The antimicrobial central venous catheters market segment is expected to grow due to the increased focus on prevention of Healthcare Associated Infection (HAI), while the non-antimicrobial central venous catheters market segment will grow due to its low cost.

The largest central venous catheters market was that of the US, which was valued at $295m in 2010, having grown at a CAGR of 4.5% from 2003. The non-antimicrobial central venous catheters market segment was the largest market segment with revenues of $193.9m in 2010. The antimicrobial central venous catheters market segment was valued at $101.1m in 2010.

Patients who require the external administration of nutrition and medication consequently require the use of central venous catheters. The American Cancer Society estimates that about 1.64 million new cases of cancer will be detected in the US in 2012. The National Institutes of Health (NIH) estimate that the total costs due to cancer in 2007 were $226.8 billion, comprising $103.8 billion in direct medical costs and $123 billion in indirect mortality costs. Significant attention towards prevention of HAIs by the healthcare payers is also expected to drive the market growth.

For Sample Pages, please click or add the below link to your browser:
http://www.globaldata.com/ReportStore/RequestSamplePages....

Patients suffering from diseases such as cancer are often unable to receive fluids or medication via the traditional route, meaning that they must be administered externally. This is done using a central venous catheter, which is placed on the central line.

The International Agency for Research on Cancer (IARC) estimates that the total number of new cancer cases globally will rise to 21.4 million by 2030 and that the total number of deaths from cancer will reach 13.2 million. The growth and aging of the population are the main factors contributing to the rise in the number of cancer cases.

GlobalData’s new report, “Central Venous Catheters - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global central venous catheters market. The report provides market landscape, competitive landscape and market trends information on the central venous catheters market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

For further details, please click or add the below link to your browser:
http://www.globaldata.com/ReportStore/Report.aspx?ID=Cent...

Visit our report store: http://www.globaldata.com/reportstore

For more details contact:
pressreleases@globaldata.com
           
North America:    +1 646 395 5477
Europe:        +44 207 753 4299
           +44 1204 543 533
Asia Pacific:       +91 40 6616 6782

# # #

GlobalData is a global market intelligence services company providing information research and analysis products and services.